Skip to content

the Effect of Erector Spinae Plane Block on Fentanyl Consumption During Abdominal Hysterectomy

the Effect of Erector Spinae Plane Block on Fentanyl Consumption During Abdominal Hysterectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05072184
Enrollment
100
Registered
2021-10-08
Start date
2021-10-01
Completion date
2022-07-15
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Brief summary

This study aims to evaluate the effects of erector spinae plane block on intraoperative fentanyl consumption in patients undergoing abdominal hysterectomy under general anesthesia. To our knowledge, no study in the literature demonstrates this effect.

Detailed description

This study will be performed in Fayoum University hospital after approval of the institutional ethics committee and written informed consent. This study will be conducted as a prospective, randomized, double-blind, parallel-group clinical trial. Inclusion criteria: * American Society of Anesthesiologists (ASA) physical status I, II patients who will be scheduled for elective abdominal hysterectomy. * Age range above 18. Exclusion criteria: * Patient refusal. * Significant renal, hepatic and cardiovascular diseases. * History of allergy to one of the study drugs. * Any contraindication to regional anesthesia such as local infection or bleeding disorders. * Chronic opioid use, history of chronic pain and cognitive disorders. The patients will be randomized into two groups: ESP block group who will receive preoperative US-guided bilateral ESP block with 20 ml of bupivacaine 0.25% on each side and Control group who will undergo the same procedure but with an injection of 20 ml of saline on a 1:1 ratio using a computer-generated random table. The patient's assigned group information will be elicited from a sealed opaque envelope by the anesthesiologist who will perform the ESP block and will not be involved in further data collection or patient care. The patients and both the surgical and anesthesia teams, who are responsible for patient care and data collection are blinded from the group assignments.

Interventions

PROCEDUREESP block

ESP block group who will receive preoperative US-guided bilateral ESP block with 20 ml of bupivacaine 0.25% on each side

Sponsors

Fayoum University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

This study will be conducted as a prospective, randomized, double-blind, parallel-group clinical trial.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

\- Inclusion criteria: * American Society of Anesthesiologists (ASA) physical status I, II patients who will be scheduled for elective abdominal hysterectomy. * Age range 18-70 years

Exclusion criteria

* Patient refusal. * Significant renal, hepatic, and cardiovascular diseases. * History of allergy to one of the study drugs. * Any contraindication to regional anesthesia such as local infection or bleeding disorders. * Chronic opioid use, history of chronic pain and cognitive disorders.

Design outcomes

Primary

MeasureTime frameDescription
The total intraoperative fentanyl consumption (μg)operative time in hoursthe total doses of intraoperative fentanyl consumption in (μg)

Secondary

MeasureTime frameDescription
intraoperative sevoflurane consumption (ml)operative time in hoursintraoperative sevoflurane consumption (ml)
post-operative fentanyl consumption in (μg)the first 24 hours postoperativepost-operative fentanyl consumption in the first 24 hours (μg)
VAS scorethe first 24 hours postoperativevisual analog score
mean operative times (min)operative times in (min)operative times duration in (min)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026